Repligen
RGEN
#1858
Rank
ยฃ8.29 B
Marketcap
ยฃ129.73
Share price
2.97%
Change (1 day)
17.15%
Change (1 year)
Categories

EPS for Repligen (RGEN)

EPS in 2023 (TTM): ยฃ1.70

According to Repligen 's latest financial reports the company's current EPS (TTM) is -ยฃ0.15. In 2022 the company made an earnings per share (EPS) of ยฃ2.51 an increase over its 2021 EPS that were of ยฃ1.75.

EPS history for Repligen from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ1.70-32.25%
2022ยฃ2.5143.59%
2021ยฃ1.75105.26%
2020ยฃ0.85153.33%
2019ยฃ0.3418.42%
2018ยฃ0.28-47.95%
2017ยฃ0.55108.57%
2016ยฃ0.2620.69%
2015ยฃ0.2216%
2014ยฃ0.19-48.98%
2013ยฃ0.376.52%
2012ยฃ0.34-512.88%
2011-ยฃ0.08331-1214.13%
2010ยฃ0.007478-106.25%
2009-ยฃ0.12-200%
2008ยฃ0.12-87.79%
2007ยฃ0.98-2283.33%
2006-ยฃ0.04487-300%
2005ยฃ0.02243-115%
2004-ยฃ0.15-25.93%
2003-ยฃ0.2080%
2002-ยฃ0.11-21.05%
2001-ยฃ0.14-0%
2000-ยฃ0.14-17.39%
1999-ยฃ0.17245.01%
1998-ยฃ0.0498533.33%
1997-ยฃ0.03739-87.18%
1996-ยฃ0.29

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
ยฃ0.57-480.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
ยฃ14.20-9,595.00%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
ยฃ6.53-4,465.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ3.38-2,360.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-ยฃ0.28 90.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-ยฃ1.14 660.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ5.27-3,625.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
ยฃ0.87-685.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.28-290.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-ยฃ3.62 2,320.00%๐Ÿ‡บ๐Ÿ‡ธ USA